Safety Profile (Phase 2) The most common adverse events were gastrointestinal and consistent with the incretin drug class: - Nausea - Diarrhea - Vomiting - Constipation - Decreased appetite These GI events were dose-related, mostly mild to moderate, and partially mitigated by starting at a lower initial dose (2 mg vs
Product Facts Supplement Facts Serving Size 1 Vegan Capsule Servings Per Container 60 *Daily Value not established
Hermansen K, Davies M, Derezinski T, Martinez Ravn G, Clauson P, Home P
There is no subscription to cancel
Silent and symptomatic primary carnitine deficiency within the same family due to identical mutations in the organic cation/carnitine transporter OCTN2
However, neither is FDA-approved for human use and both are banned in many athletic contexts